PM
AGN

Penbrook Management’s Allergan plc AGN Stock Holding History

Penbrook Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,886
Closed -$511K – 107
2020
Q1 		$511K Hold
2,886
– – 0.65% 46
2019
Q4 		$552K Hold
2,886
– – 0.54% 63
2019
Q3 		$486K Sell
2,886
-100
-3% -$16.3K 0.53% 65
2019
Q2 		$500K Sell
2,986
-890
-23% -$123K 0.54% 65
2019
Q1 		$567K Sell
3,876
-490
-11% -$71K 0.59% 59
2018
Q4 		$584K Buy
4,366
+560
+15% +$91.8K 0.67% 50
2018
Q3 		$725K Sell
3,806
-1,850
-33% -$340K 0.69% 51
2018
Q2 		$943K Sell
5,656
-20
-0.4% -$3.21K 0.91% 39
2018
Q1 		$955K Sell
5,676
-300
-5% -$50.3K 0.95% 35
2017
Q4 		$978K Buy
+5,976
New +$1.07M 0.88% 34
2016
Q3 		$1.37M Hold
5,950
– – 1.48% 19
2016
Q2 		$1.38M Buy
5,950
+1,680
+39% +$387K 1.52% 15
2016
Q1 		$1.14M Hold
4,270
– – 1.26% 25
2015
Q4 		$1.33M Hold
4,270
– – 1.37% 22
2015
Q3 		$1.16M Buy
4,270
+50
+1% +$15.4K 1.23% 30
2015
Q2 		$1.28M Buy
4,220
+1,057
+33% +$315K 1.22% 34
2015
Q1 		$941K Buy
+3,163
New +$902K 0.84% 49

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Penbrook Management's AGN Position: Q2 2020 in Review

Penbrook Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,886 shares — an estimated $511K sold.

Penbrook Management first reported a position in AGN in Q1 2015 and held it in 17 quarters. The position peaked at $1.38M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Penbrook Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Penbrook Management sold 2,886 Allergan plc shares in Q2 2020, an estimated $511K.
  • Penbrook Management first reported a position in Allergan plc in Q1 2015 and held it in 17 quarters.
  • Penbrook Management's Allergan plc position peaked at $1.38M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Penbrook Management's 13F filing for Q2 2020, filed 28 Jul 2020.